Trial Search Results

B-mode Ultrasound Imaging in Detecting Early Liver Cancer

This pilot trial studies how well B-mode ultrasound imaging works in detecting liver cancer that is early in its growth and may not have spread to other parts of the body. Diagnostic procedures, such as B-mode ultrasound imaging, may help find and diagnose liver cancer and find out how far the disease has spread.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Other: Ultrasound Tomography




Inclusion Criteria:

For Healthy Volunteers

   1. Patients over 18 years of age.

   2. Must have no known medical problems and have had a full medical exam within 6 months
   of the study. If healthy volunteers have not had a full medical exam within 6 months
   of the study, one of the ultrasound physicians will conduct the medical exam prior to
   any study procedures.

For HCC patients

   1. Patients over 18 years of age.

   2. Patient with confirmed diagnosis of HCC, and untreated or Patients with Suspected HCC
   (Suspected HCC nodules should preferably be smaller than 3 cm and preferably within 6
   cm in depth of the transducer head to minimize attenuation) and untreated or Patients
   at a higher risk of HCC undergoing a screening program by Ultrasound.

Exclusion Criteria:

For Healthy volunteers

1. Patients who are not likely to comply with the protocol requirements.

For HCC patients

   1. Patients should not be taking other Investigational Agents.

   2. Concomitant medications for treatment of the target lesion.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305